Company Innovotech Inc Toronto S.E.
Equities
IOT
CA45772U1049
Biotechnology & Medical Research
Business Summary
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Contract Research Fees
80.8
%
| 1 | 79.1 % | 1 | 80.8 % | +7.27% |
Seed Treatment
19.2
%
| 0 | 19.5 % | 0 | 19.2 % | +3.80% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
87.5
%
| 1 | 85.1 % | 1 | 87.5 % | +8.10% |
Rest of World
10.7
%
| 0 | 12.1 % | 0 | 10.7 % | -7.05% |
Canada
1.7
%
| 0 | 2.8 % | 0 | 1.7 % | -35.10% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Craig Milne
CEO | Chief Executive Officer | - | 19-07-18 |
Director of Finance/CFO | - | 13-04-29 | |
James Timourian
CHM | Chairman | - | 02-10-21 |
Chief Tech/Sci/R&D Officer | - | 09-12-31 | |
Tyler Boone
COO | Chief Operating Officer | - | 16-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Karen L. Farkas
BRD | Director/Board Member | - | 19-12-14 |
James Timourian
CHM | Chairman | - | 02-10-21 |
Director of Finance/CFO | - | 13-04-29 | |
Craig Milne
CEO | Chief Executive Officer | - | 19-07-18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 39,003,612 | 22,282,057 ( 57.13 %) | 0 | 57.13 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+24.74% | 47.54B | |
-0.47% | 41.96B | |
+43.96% | 41.55B | |
+25.40% | 30.36B | |
+17.96% | 27.61B | |
-4.47% | 28.7B | |
+50.73% | 14.7B | |
+42.56% | 13.51B | |
+1.46% | 12.34B |